Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor–mediated cell death

Eva De Smedt, Julie Devin, Catharina Muylaert, Nicolas Robert, Guilhem Requirand, Philip Vlummens, Laure Vincent, Guillaume Cartron, Ken Maes, Jerome Moreaux, Elke De Bruyne

Blood Adv (2021) 5 (9): 2325–2338.

https://doi.org/10.1182/bloodadvances.2020003217

Published: 2021

Includes: Supplemental data

Journal Articles

Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation

Burak Kalin, Yvette van Norden, Michel van Gelder, Dimitri Breems, Johan Maertens, Mojca Jongen-Lavrencic, Annoek E. C. Broers, Eric Braakman, Tim Grob, Wendelien Zeijlemaker, Gert J. Ossenkoppele, Ellen Meijer, Jan J. Cornelissen

Blood Adv (2020) 4 (18): 4430–4437.

https://doi.org/10.1182/bloodadvances.2020002074

Published: 2020

Includes: Supplemental data

Journal Articles

CD81 knockout promotes chemosensitivity and disrupts in vivo homing and engraftment in acute lymphoblastic leukemia

Anthony Quagliano, Anilkumar Gopalakrishnapillai, E. Anders Kolb, Sonali P. Barwe

Blood Adv (2020) 4 (18): 4393–4405.

https://doi.org/10.1182/bloodadvances.2020001592

Published: 2020

Includes: Supplemental data

Journal Articles

Specific patterns of H3K79 methylation influence genetic interaction of oncogenes in AML

Molly C. Kingsley, Hongbo M. Xie, Bo-Rui Chen, Simone S. Riedel, Taylor Pastuer, Madelyn K. Bollig, Tyler Shank, Clara Libbrecht, Sally P. Stabler, Aniruddha J. Deshpande, Andrew M. Intlekofer, Kathrin M. Bernt

Blood Adv (2020) 4 (13): 3109–3122.

https://doi.org/10.1182/bloodadvances.2020001922

Published: 2020

Includes: Supplemental data

Journal Articles

Pan D, Rampal R, Mascarenhaset J. Clinical developments in epigenetic-directed therapies in acute myeloid leukemia. Blood Adv. 2020;4(5):970-982.

Blood Adv (2020) 4 (7): 1220.

https://doi.org/10.1182/bloodadvances.2020001862

Published: 2020

Journal Articles

CLL intraclonal fractions exhibit established and recently acquired patterns of DNA methylation

Boris A. Bartholdy, Xiahoua Wang, Xiao-Jie Yan, Marién Pascual, Manxia Fan, Jacqueline Barrientos, Steven L. Allen, Jose Angel Martinez-Climent, Kanti R. Rai, Nicholas Chiorazzi, Matthew D. Scharff, Sergio Roa

Blood Adv (2020) 4 (5): 893–905.

https://doi.org/10.1182/bloodadvances.2019000817

Published: 2020

Includes: Supplemental data

Journal Articles

Clinical developments in epigenetic-directed therapies in acute myeloid leukemia

Darren Pan, Raajit Rampal, John Mascarenhas

Blood Adv (2020) 4 (5): 970–982.

https://doi.org/10.1182/bloodadvances.2019001245

Published: 2020

Journal Articles

A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia

Kirk E. Cahill, Yasmin H. Karimi, Theodore G. Karrison, Nitin Jain, Margaret Green, Howard Weiner, Noreen Fulton, Sabah Kadri, Lucy A. Godley, Andrew S. Artz, Hongtao Liu, Michael J. Thirman, Michelle M. Le Beau, Megan E. McNerney, Jeremy Segal, Richard A. Larson, Wendy Stock, Olatoyosi Odenike

Blood Adv (2020) 4 (4): 599–606.

https://doi.org/10.1182/bloodadvances.2019000795

Published: 2020

Includes: Supplemental data

Journal Articles

Clonal dynamics in chronic lymphocytic leukemia

Catherine Gutierrez, Catherine J. Wu

Blood Adv (2019) 3 (22): 3759–3769.

https://doi.org/10.1182/bloodadvances.2019000367

Published: 2019

Journal Articles

DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes

Brian Reilly, Tiffany N. Tanaka, Dinh Diep, Huwate Yeerna, Pablo Tamayo, Kun Zhang, Rafael Bejar

Blood Adv (2019) 3 (19): 2845–2858.

https://doi.org/10.1182/bloodadvances.2019000192

Published: 2019

Includes: Supplemental data

Journal Articles

Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials

Blood Adv (2019) 3 (16): 2474–2481.

https://doi.org/10.1182/bloodadvances.2019000237

Published: 2019

Includes: Supplemental data

Journal Articles

Challenges and approaches to implementing master/basket trials in oncology

Amy Burd, Richard L. Schilsky, John C. Byrd, Ross L. Levine, Vassiliki A. Papadimitrakopoulou, Roy S. Herbst, Mary W. Redman, Brian J. Druker, David R. Gandara

Blood Adv (2019) 3 (14): 2237–2243.

https://doi.org/10.1182/bloodadvances.2019031229

Published: 2019

Journal Articles

Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma

Blood Adv (2019) 3 (4): 588–595.

https://doi.org/10.1182/bloodadvances.2018028340

Published: 2019

Includes: Supplemental data

Journal Articles

Cells of adult T-cell leukemia evade HTLV-1 Tax/NF-κB hyperactivation–induced senescence

Abigail M. Druck Shudofsky, Chou-Zen Giam

Blood Adv (2019) 3 (4): 564–569.

https://doi.org/10.1182/bloodadvances.2018029322

Published: 2019

Journal Articles

Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis

Catharina Wenk, Anne-Kathrin Garz, Sonja Grath, Christina Huberle, Denis Witham, Marie Weickert, Roberto Malinverni, Julia Niggemeyer, Michèle Kyncl, Judith Hecker, Charlotta Pagel, Christopher B. Mulholland, Catharina Müller-Thomas, Heinrich Leonhardt, Florian Bassermann, Robert A. J. Oostendorp, Klaus H. Metzeler, Marcus Buschbeck, Katharina S. Götze

Blood Adv (2018) 2 (23): 3447–3461.

https://doi.org/10.1182/bloodadvances.2018022053

Published: 2018

Includes: Supplemental data

Journal Articles

Clinical consequences of clonal hematopoiesis of indeterminate potential

David P. Steensma

Blood Adv (2018) 2 (22): 3404–3410.

https://doi.org/10.1182/bloodadvances.2018020222

Published: 2018

Journal Articles

Defining the epigenetic status of blood cells using a cyanine-based fluorescent probe for PRMT1

Hairui Su, Chiao-Wang Sun, Szu-Mam Liu, Xin He, Hao Hu, Kevin M. Pawlik, Tim M. Townes, Xiaosi Han, Christopher A. Klug, Maged Henary, Yabing Chen, Ling Li, Y. George Zheng, Xinyang Zhao

Blood Adv (2018) 2 (21): 2829–2836.

https://doi.org/10.1182/bloodadvances.2018020727

Published: 2018

Includes: Supplemental data

Journal Articles

Molecular pathophysiology of the myelodysplastic syndromes: insights for targeted therapy

Alex Aleshin, Peter L. Greenberg

Blood Adv (2018) 2 (20): 2787–2797.

https://doi.org/10.1182/bloodadvances.2018015834

Published: 2018

Journal Articles

ASXL1 impairs osteoclast formation by epigenetic regulation of NFATc1

Nidhi Rohatgi, Wei Zou, Patrick L. Collins, Jonathan R. Brestoff, Timothy H. Chen, Yousef Abu-Amer, Steven L. Teitelbaum

Blood Adv (2018) 2 (19): 2467–2477.

https://doi.org/10.1182/bloodadvances.2018018309

Published: 2018

Includes: Supplemental data

Journal Articles

Epigenetic programming of T cells impacts immune reconstitution in hematopoietic stem cell transplant recipients

Kristine Hardy, Corey Smith, Wen Juan Tu, Robert McCuaig, Archana Panikkar, Vijayendra Dasari, Fan Wu, Siok-Keen Tey, Geoffrey R. Hill, Rajiv Khanna, Sudha Rao

Blood Adv (2018) 2 (6): 656–668.

https://doi.org/10.1182/bloodadvances.2018015909

Published: 2018

Includes: Supplemental data

NARROW

G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor–mediated cell death

Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation

CD81 knockout promotes chemosensitivity and disrupts in vivo homing and engraftment in acute lymphoblastic leukemia

Specific patterns of H3K79 methylation influence genetic interaction of oncogenes in AML

Pan D, Rampal R, Mascarenhaset J. Clinical developments in epigenetic-directed therapies in acute myeloid leukemia. Blood Adv. 2020;4(5):970-982.

CLL intraclonal fractions exhibit established and recently acquired patterns of DNA methylation

Clinical developments in epigenetic-directed therapies in acute myeloid leukemia

A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia

Clonal dynamics in chronic lymphocytic leukemia

DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes

Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials

Challenges and approaches to implementing master/basket trials in oncology

Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma

Cells of adult T-cell leukemia evade HTLV-1 Tax/NF-κB hyperactivation–induced senescence

Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis

Clinical consequences of clonal hematopoiesis of indeterminate potential

Defining the epigenetic status of blood cells using a cyanine-based fluorescent probe for PRMT1

Molecular pathophysiology of the myelodysplastic syndromes: insights for targeted therapy

ASXL1 impairs osteoclast formation by epigenetic regulation of NFATc1

Epigenetic programming of T cells impacts immune reconstitution in hematopoietic stem cell transplant recipients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only